Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details)

v3.25.3
Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Accounts payable:    
Clinical and regulatory expenses $ 544 $ 452
Professional fees 797 904
Selling expenses 1,485 1,553
Manufacturing costs 777 706
Non-employee director compensation 1,035 966
Other vendors 724 594
Total accounts payable 5,362 5,175
Accrued interest payable, related parties 1,466 1,145
Accrued interest payable 5,369 2,874
Accrued expenses:    
Payroll expenses 516 323
Government rebates and other rebates 8,639 7,229
Other accrued expenses 407 180
Total accrued expenses 9,562 7,732
Total accounts payable and accrued expenses $ 21,759 $ 16,926